Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension

Inhaled nitric oxide (iNO) is used for acute vasoreactivity testing in pulmonary arterial hypertension (PAH) patients. Inhaled epoprostenol (iPGI(2)) has pulmonary selectivity and is less costly. We sought to compare acute hemodynamic effects of iNO (20 ppm) and iPGI(2) (50 ng/kg/min) and determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Preston, Ioana R., Sagliani, Kristen D., Roberts, Kari E., Shah, Archan M., DeSouza, Shilpa A., Howard, William, Brennan, John, Hill, Nicholas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641742/
https://www.ncbi.nlm.nih.gov/pubmed/23662176
http://dx.doi.org/10.4103/2045-8932.109916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641742/
https://www.ncbi.nlm.nih.gov/pubmed/23662176
http://dx.doi.org/10.4103/2045-8932.109916

Ejemplares similares